[Form 4] Veracyte, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Jonathan Wygant, Veracyte (VCYT) reporting person, disclosed a non-sale disposition on 09/02/2025 in which 1,648 shares of common stock were withheld to satisfy tax withholding obligations arising from the vesting of restricted stock units; the transaction is reported at a per-share value of $30.11. The filing clarifies this withholding does not represent a sale.

After the withholding, the reporting person beneficially owns 46,779 shares, which includes 512 shares purchased on July 30, 2025 under the company ESPP. The reporting person is identified as an officer with the title VP, Chief Accounting Officer.

Insights

Financial Analyst

TL;DR: Modest tax-withhold share disposition from RSU vesting; ownership remains concentrated and includes recent ESPP purchase.

The 1,648-share withholding at $30.11 per share is a routine, non-sale transaction tied to RSU vesting and tax obligations, not a liquidity-driven sale. Such withholdings reduce outstanding personal share count but do not change the reporter's economic exposure from vested compensation materially. The disclosure that 512 shares were acquired via the ESPP indicates continued participation in company equity compensation programs. Overall, this Form 4 shows routine insider activity rather than a change in strategic ownership.

Corporate Governance Expert

TL;DR: Disclosure is standard and compliant; withholding for taxes is common and explicitly noted as not a sale.

The Form 4 appropriately documents the withholding of shares to satisfy tax obligations tied to RSU vesting and provides the remaining beneficial ownership figure. Identification of the reporting person as VP, Chief Accounting Officer clarifies insider status for stakeholders. There are no indications of unusual transactions, pledges, or transfers to affiliates; disclosures appear complete for the described events.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Wygant Jonathan

(Last) (First) (Middle)

6000 SHORELINE COURT, SUITE 300

(Street)

SOUTH SAN FRANCISCO CA 94080

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	VP, Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/02/2025		F(1)		1,648	D	$30.11	46,779(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2025 and does not represent a sale.

2. Includes 512 shares of common stock purchased on July 30, 2025 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.

Remarks:

	/s/ Jonathan Wygant	09/04/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Jonathan Wygant report on Form 4 for VCYT?

The Form 4 reports that 1,648 shares were withheld to satisfy tax withholding obligations related to RSU vesting on 09/02/2025.

Was the 1,648-share withholding a sale of Veracyte (VCYT) stock?

No. The filing explicitly states the withholding does not represent a sale and was done to satisfy tax obligations.

How many Veracyte shares does the reporting person beneficially own after the transaction?

The reporting person beneficially owns 46,779 shares following the reported transaction.

Did the Form 4 disclose any purchases under the employee stock purchase plan (ESPP)?

Yes. The filing states 512 shares were purchased on July 30, 2025 pursuant to the Veracyte Employee Stock Purchase Plan.

What is the per-share value reported for the withheld shares?

The withheld shares are reported at a value of $30.11 per share.